Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) fell 4.6% during trading on Monday . The company traded as low as $39.72 and last traded at $40.00. 109,342 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 656,650 shares. The stock had previously closed at $41.94. Wall Street […]
Rhythm Pharmaceuticals (NASDAQ:RYTM) Posts Earnings Results, Hits Expectations themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of "Buy" by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s share price was down 4.4% on Thursday . The stock traded as low as $43.43 and last traded at $46.68. Approximately 90,505 shares were traded during mid-day trading, a decline of 87% from the average daily volume of 686,012 shares. The stock had previously closed at $48.81. […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) CFO Hunter C. Smith sold 1,209 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $51.38, for a total transaction of $62,118.42. Following the transaction, the chief financial officer now directly owns 80,413 shares in […]